Tokunaga et al. [28] showed that RTX decreases CD40- and CD80-expression in activated B-cells in patients with systemic lupus-erythematosus, and down-regulates CD40L and CD69 on CD4-positive cells. Here, CD40LG is linked to systemic lupus erythematosus.